Mushrooms
Listed hallucinogenic mushroom fruiting bodies remain prohibited. Drying, grinding, preparing, or selling them online does not remove that controlled status.
International law · reviewed July 22, 2026
Psilocybin in the Netherlands: mushrooms and sclerotia are treated differently
The Netherlands placed hallucinogenic mushroom fruiting bodies on Opium Act List II in 2008. In April 2026, the Dutch Supreme Court confirmed that magic truffles, or sclerotia, fall outside the Opium Act and may be cultivated and traded. This product-form distinction is not general legalization of psilocybin mushrooms and is not an approved medical treatment system.
Status in brief
What the current framework actually permits
Magic truffles
Sclerotia are outside the Opium Act under the Supreme Court’s 2026 ruling and may be cultivated and traded domestically. Their status is based on product classification, not the cannabis coffee-shop tolerance policy.
Borders and medical claims
Dutch domestic availability does not decide whether export or import is lawful in another country. Truffle retail also does not create licensed psychedelic healthcare or authorize medical claims.
Boundary
Product form matters, and destination law still applies
Psilocybin and psilocin themselves remain controlled, as do the mushroom forms placed on the statutory lists. A lawful Dutch truffle sale does not make prohibited mushrooms, extracts, preparations, or cross-border delivery legal.
Product-format context
Product descriptions, laboratory documentation, fulfillment policies, and client support remain on iMicrodosing.com. Deeper research remains on iMicrodosing.org.
Educational information only. Not medical advice. 21+ only.